Special Issue

Targeting of immune system in anti-tumor combined therapies

Submission Deadline: 31 Dec 2020

Guest Editors

  • Portrait of Guest Editor Francesco Novelli

    Francesco Novelli

    PhD, Uiversity of Turin

    Interests: 130 publications, 48 grants, Editor of 0

  • Portrait of Guest Editor Paola Cappello

    Paola Cappello

    Univ Turin, Dept Mol Biotechnol & Hlth Sci, Via Nizza 52, Turin, Italy;

    Interests: 80 publications, 4 grants, Editor of 0

Keywords

  • Cancer
  • Immune System
  • Therapeutics

Manuscript Submission Information

Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. 

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted manuscripts should be well formatted in good English.

Published Papers (4)

Open Access Review
1518
642
32
Review
322
150
7
Review
255
94
14
Review
442
66
20